TIDMMGP
RNS Number : 5790E
Medica Group PLC
30 June 2023
30 June 2023
Medica Group Plc
Result of Annual General Meeting
Medica Group PLC (LSE:MGP, "Medica" or the "Company"), an
international provider of high-quality telemedicine services,
announces that, at its Annual General Meeting held at 10.30am today
at the offices of DLA Piper, 160 Aldersgate Street, London EC1A
4HT, all resolutions put to the meeting were duly passed.
Details of the voting are as follows:
Resolution For/ % Against % Total Withheld
Discretion For/ (Number Against votes (Number
(Number Discretion of votes) of votes)
of
votes)
Ordinary Business
Ordinary Resolutions
To receive and
adopt the
annual
report,
accounts
and the
auditor's
1. report 66,479,561 100.00 0 0.00 66,479,561 249,911
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To approve the
Directors'
Remuneration
2. Report 37,121,768 57.83 27,067,040 42.17 64,188,808 2,540,664
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
3. To declare a See note below*
final dividend
-------------------------- --------------------------------------------------------------------------
To re-appoint
Grant Thornton
UK LLP as
4. auditors 66,081,401 99.40 399,054 0.60 66,480,455 249,017
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To authorise
the Directors
to determine
the
remuneration
of the
5. auditors 66,716,249 99.98 10,759 0.02 66,727,008 2,464
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To re-elect
Roy
Davis as a
6. Director 65,870,471 99.21 526,381 0.79 66,396,852 332,620
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To re-elect
Barbara
Moorhouse as
7. a Director 66,204,304 99.22 522,538 0.78 66,726,842 2,630
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To re-elect
Joanne
Easton as a
8. Director 66,204,415 99.21 524,189 0.79 66,728,604 868
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To re-elect Dr
Junaid Bajwa
9. as a Director 65,093,295 97.92 1,384,696 2.08 66,477,991 251,481
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To re-elect
Stuart
Quin as a
10. Director 66,726,029 100.00 813 0.00 66,726,842 2,630
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To re-elect
Richard
Jones as a
11. Director 66,477,880 100.00 111 0.00 66,477,991 251,481
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
Special Business
Ordinary resolution
General
authority
to allot
shares
pursuant to
Section
551 Companies
12. Act 2006 66,717,902 99.99 8,940 0.01 66,726,842 2,630
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
Special resolutions
Standard
pre-emption
13. disapplication 64,925,423 97.30 1,800,717 2.70 66,726,140 3,332
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
Additional
pre-emption
disapplication
for the
purpose
of financing
an acquisition
or other
capital
14. investment 64,672,763 96.92 2,053,377 3.08 66,726,140 3,332
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
Authority to
make market
purchases
of up to
12,288,363
15. shares 65,844,437 99.62 248,149 0.38 66,092,586 636,886
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
To authorise
general
meetings
to be held on
14 clear days'
16. notice 66,165,995 99.16 562,609 0.84 66,728,604 868
-------------------------- ----------- ----------- ----------- --------- ----------- -----------
* As previously communicated by an RNS announcement this
morning, the resolution to declare a final dividend for the year
ended 31 December 2022 of 1.88 pence per share ("2022 Final
Dividend") (Resolution 3) was withdrawn prior to, and was not
presented to, the AGM. This will ensure shareholders receive 212
pence per share in full without any reduction in respect of the
previously proposed 2022 Final Dividend as opposed to two separate
payments and in accordance with the terms of the recommended cash
acquisition for the Company by Moonlight Bidco Limited (once
effected).
For further information, please contact:
Medica Group Plc:
Stuart Quin, Chief Executive
Officer
Richard Jones, Chief Financial
Officer +44 (0)33 33 111 222
FTI Consulting
Victoria Foster Mitchell
Sam Purewal +44 (0)20 3727 1000
Liberum (Joint Broker)
Phil Walker
Richard Lindley +44 (0)20 3100 2000
Numis (Joint Broker)
Freddie Barnfield
Duncan Monteith
Euan Brown +44 (0)20 7260 1000
About Medica Group PLC
Medica (LSE:MGP) is an international provider of high-quality
telemedicine services. It is the market leader in teleradiology in
the UK and Ireland, working with more than 100 NHS Trusts and HSE
hospitals in Ireland, in addition to private hospitals, insurance
groups and diagnostic imaging companies. Its network of consultant
radiologists, radiographers and specialist doctors interpret and
report MRI, CT, ultrasound and X-ray images on behalf of healthcare
providers, using Medica's bespoke, secure technology platform for
fast and responsive delivery. The company's core services include
NightHawk, an urgent, out-of-hours offering available to clients
24/7 with dedicated pathways for stroke and major trauma, and
Elective, for routine reporting.
In Ireland, Medica carries out patient scanning, as well as
reporting, and runs a diabetic retinopathy screening programme for
the National Screening Service. Through its US business, RadMD,
Medica provides global pharmaceutical and biotech companies, as
well as contract research organisations with specialist imaging
services for clinical trials.
For more information please visit: www.medicagroupplc.com
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGWPURCQUPWGUU
(END) Dow Jones Newswires
June 30, 2023 06:53 ET (10:53 GMT)
Medica (LSE:MGP)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Medica (LSE:MGP)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
